• Home
  • About Us
  • Products
    • Formulation Products
    • API Product
    • Advance Interrmediates Product
  • Services
  • Jobs & careers
  • News/Events
  • Contact Us

Generic formulation development,manufacturing and marketing.

Formulation Development & Marketing (USA)
THINQ Has more than a dozen prescription products in the U.S. market today and 30 products under development

We have already achieved 12 % market share in most of the products we launched and more than 35% to 50% market share in few products


Formulation Development & Marketing Business Model


Supporting our Manufacturing partner for: Sales-Marketing-Customer Service- Product Selection-Financial Analysis- Regulatory


Supporting our Manufacturers and Marketing partners for: Inventory positioning – Ordering - Warehousing- Distribution - Regulatory


Supporting our Marketing partners for: Product Development-Manufacturing- Regulatory

APIs, CRAMS and Advanced Intermediates Development & Marketing

Mr. Shekhar Nadkarni who is a promoter and founder of THINQ Pharma-CRO is widely known personality in the CRAMs industry due to his 30+ years of experience. He was one of the pioneers to start off with the CRAMs business in India.

We have over 25 years’ experience in this field and we can say with confidence that we have the ability to develop most chemistry. In the past we had Robert Grubbs a Nobel Laureate in our Technical Board. We have worked with almost all MNCs including Japanese companies developing intermediates with difficult technology.

We also develop products on exclusive basis in our R&D Centre which has almost all modernized and latest equipment required for developing Pharma APIs and Intermediates. Our R&D Centre is over 6000 sq feet with work going on extension of another 6000 sq feet area. We do our development in a confidential and exclusive basis and simultaneously for 12 products.

We manufacture advance and bulk intermediates on multi ton level under Exclusive and Confidentiality Agreements with our associate Indian manufacturers having cGMP compliance.
Types of Reactions handled
Asymmetric catalytic hydrogenation Heck reaction
Multi Step synthesis Mitsunobu reaction
Suzuki coupling Sonogashira coupling
Asymmetric oxidation Wittig Reaction
Hydrogenation High Vacuum Distillations
High Temperature reactions Chiral separations
Swern Oxidation  

Clinical studies and Clinical data management

CRO business established in 2003 with THINQ being the first Indian CRO to procure and implement Oracle Clinical.

Provides
Trial Budgeting Medical Writing
Regulatory Affair Clinical Operations
Data Management Statistical Analysis
Pharmaco-vigilance in collaboration with our associate.  

Regulatory Services

We have a strong team to provide regulatory services ranging from BA/BE studies, filing for DMF, filing for ANDAs, Post approval change management etc.

Our expertise lies quality dossiers thereby resulting timely approvals. We also provide services for Quality – GMP compliance.

Home About Us Products Services News & Events Jobs & careers Contact Us

Copyright © 2014 THINQ Pharma. All Rights Reserved Designe By Deepali Sawant